@article{f32208d5bf24453fbf565b84a321b283,
title = "Clinical outcomes for plasma-based comprehensive genomic profiling versus standard-of-care tissue testing in advanced non-small cell lung cancer",
author = "Page, \{Ray D.\} and Drusbosky, \{Leylah M.\} and Hiba Dada and Raymond, \{Victoria M.\} and Daniel, \{Davey B.\} and Divers, \{Stephen G.\} and Reckamp, \{Karen L.\} and Villalona-Calero, \{Miguel A.\} and Daniel Dix and Odegaard, \{Justin I.\} and Lanman, \{Richard B.\} and Papadimitrakopoulou, \{Vassiliki A.\} and Papadimitrakopoulou, \{Vassiliki A.\} and Leighl, \{Natasha B.\}",
note = "Available online 10 October 2021 : Somatic genomic testing is recommended by numerous expert guidelines to inform targeted therapy treatment for patients with advanced nonsquamous non-small cell lung cancer (aNSCLC). The NILE study was a prospective observational study that demonstrated noninferiority of cell-free circulating tumor DNA (cfDNA)-based tumor genotyping compared to tissue-based genotyping to find targetable genomic alterations in patients with newly diagnosed nonsquamous aNSCLC.",
year = "2021",
month = oct,
day = "10",
doi = "10.1016/J.CLLC.2021.10.001",
language = "American English",
journal = "Clinical Lung Cancer",
issn = "1938-0690",
publisher = "Elsevier",
}